Ling‐Kai Chang
Papers
1
Total Citations
12
H-Index
1
About
Ling-Kai Chang is a pioneering interventional pulmonologist whose work centers on advancing minimally invasive diagnostic techniques for lung cancer, the leading cause of cancer mortality in Taiwan and globally. His major contributions focus on integrating advanced imaging technologies to improve the accuracy and safety of peripheral pulmonary nodule (PPN) biopsies. In his landmark 2023 case series, Chang demonstrated the clinical utility of cone-beam computed tomography (CBCT)-derived augmented fluoroscopy in a hybrid operating room, a technique that overlays real-time 3D imaging onto traditional fluoroscopy to guide biopsies. This innovation addresses the critical challenge of sampling small, hard-to-reach nodules that are often missed by conventional bronchoscopy with radial EBUS. With 12 citations, this work has quickly influenced procedural standards in interventional pulmonology. Chang’s research bridges radiology and bronchoscopy, offering a more precise, real-time navigation solution that reduces procedural risks and improves diagnostic yield. His achievements highlight a commitment to translating cutting-edge imaging into practical, life-saving tools, making him a notable figure in the fight against lung cancer.
Research Focus
Key Achievements
Top Papers
- 1